Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising results of the company’s proprietary BMB-101 drug to treat a rare form of epilepsy, Dravet Syndrome. The chief officer also talks about the firm’s plan to list on the Nasdaq, the common misconceptions on psychedelics, and the overall outlook of the biotech company in the medical space.

Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs.


FULL DISCLOSURE: Bright Minds Biosciences is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Bright Minds Biosciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Goliath Extends Golden Gate Lode 130 Metres With 13.45 g/t Gold Equivalent Over 4.85 Metres

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Related News

Gold Heading Above $2000? – The Daily Dive feat John Mark Staude

Today on The Daily Dive, we have John-Mark Staude, CEO of Riverside Resources (TSXV: RRI)....

Tuesday, November 10, 2020, 01:00:00 PM

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

In this interview, Roger Rosmus, CEO of Goliath Resources (TSXV: GOT), discusses the company's recent...
Tuesday, July 1, 2025, 03:48:00 PM

Trillion Energy: Production To Double In Q1 — With Arthur Halleran

Returning to the Daily Dive today is Arthur Halleran, President & CEO of Trillion Energy...

Thursday, January 5, 2023, 01:30:00 PM

Gold Price Is The US Dollar’s Enemy – The Daily Dive feat Russell Starr of Trillium Gold

Returning to the Daily Dive is Russell Starr of Trillium Gold (TSXV: TGM), whom sits...

Monday, December 14, 2020, 01:00:00 PM

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Morgan Lekstrom, CEO of NexMetals Mining Corp (TSXV: NEXM) (NASDAQ: NEXM), has some solid perspectives...

Monday, August 18, 2025, 12:12:00 PM